Claudia Ordonez's Insider Trades & SAST Disclosures
Claudia Ordonez's most recent trade in Keros Therapeutics Inc was a trade of 1,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on May 11, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Claudia Ordonez.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 1,000 | 99,211 | - | - | Employee Stock Option (right to buy) | |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 50.15 per share. | 11 May 2021 | 1,000 | 0 | - | 50.2 | 50,150 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.48 per share. | 11 May 2021 | 1,000 | 1,000 | - | 0.5 | 480 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2021 | 1,000 | 100,211 | - | - | Employee Stock Option (right to buy) | |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.48 per share. | 12 Apr 2021 | 1,000 | 1,000 | - | 0.5 | 480 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 59.09 per share. | 12 Apr 2021 | 400 | 600 | - | 59.1 | 23,636 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.01 per share. | 12 Apr 2021 | 367 | 233 | - | 60.0 | 22,024 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.23 per share. | 12 Apr 2021 | 233 | 0 | - | 61.2 | 14,267 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 1,000 | 101,211 | - | - | Employee Stock Option (right to buy) | |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.48 per share. | 11 Mar 2021 | 1,000 | 1,000 | - | 0.5 | 480 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.86 per share. | 11 Mar 2021 | 605 | 0 | - | 64.9 | 39,240 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.09 per share. | 11 Mar 2021 | 395 | 605 | - | 64.1 | 25,316 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.48 per share. | 11 Feb 2021 | 1,000 | 1,000 | - | 0.5 | 480 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 1,000 | 102,211 | - | - | Employee Stock Option (right to buy) | |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.17 per share. | 11 Feb 2021 | 312 | 513 | - | 64.2 | 20,021 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 66.19 per share. | 11 Feb 2021 | 295 | 2 | - | 66.2 | 19,526 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 65.35 per share. | 11 Feb 2021 | 216 | 297 | - | 65.4 | 14,116 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.10 per share. | 11 Feb 2021 | 175 | 825 | - | 63.1 | 11,043 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 68.00 per share. | 11 Feb 2021 | 2 | 0 | - | 68 | 136 | Common Stock |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2021 | 42,250 | 42,250 | - | - | Employee Stock Option (right to buy) | |
| Keros Therapeutics Inc | Claudia Ordonez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2020 | 18,430 | 18,430 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges